Argenx Se (ARGX) Return on Sales (2016 - 2026)

Argenx Se (ARGX) posted Return on Sales of 0.0% for Q1 2026, down 7.44% on a QoQ basis from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.

Argenx Se (ARGX) Return on Sales (2016 - 2026) Analysis & Trends

Argenx Se's Return on Sales history runs 11 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Sales was 0.0% for Q1 2026 at Argenx Se, down from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.1% in Q1 2022 and bottomed at 0.09% in Q2 2022.
  • A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
  • Annual changes were most pronounced in 2022 — Return on Sales climbed 10 bps — and 2023, when it declined 10 bps.
  • Argenx Se's Return on Sales stood at 0.0% in 2022, then plunged by 76 bps to 0.0% in 2023, then jumped by 1590 bps to 0.01% in 2024, then sank by 60 bps to 0.0% in 2025, then fell by 7 bps to 0.0% in 2026.
  • Business Quant data shows ARGX's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.00%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.00%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 0.00%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.01%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.01%
Dec 31, 2022 0.00%
Sep 30, 2022 0.02%
Jun 30, 2022 -0.09%
Mar 31, 2022 0.10%
Dec 31, 2021 -0.09%
Sep 30, 2021 0.00%
Jun 30, 2021 -0.02%